<?xml version="1.0" encoding="UTF-8"?>
<p>Altogether, 24 glioma patients with (15/24) or without TAE (9/24) were included in the study. SLC7A11 expression was visualized immunohistologically and semiquantitatively rated within (1) the tumour, (2) the peritumoural and (3) remote brain parenchyma using standard algorithms.</p>
